Lyell Immunopharma · 17 hours ago
Scientist II or Sr. Scientist, Analytical Development
Seattle, Washington, United States
Full-time
Onsite
Mid, Senior Level, Lead/Staff
$140K/yr - $180K/yr
9+ years expLyell Immunopharma is a clinical-stage company advancing next-generation CAR T-cell therapies for cancer treatment. The Scientist II or Sr. Scientist in Analytical Development will lead a product characterization team, focusing on characterizing drug products and collaborating across various teams to support assay development and validation.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Design, develop, execute, and document flow cytometry/cell/molecular based analytical methods for product characterization and investigations
Support product characterization activities, including comparability assessments in support of product life cycle management
Partner in the transfer of qualified assays within AD and to QC, and support assay validation and investigations
Develop and deliver scientific presentations, prepare clear and concise technical reports, participate in project teams as needed
Participate in the evaluation of new analytical technologies and their implementation
Provide analytical support to cross-functional project teams
Revise, review, and author assay standard operating procedures and ELNs
Contribute to building a culture that encourages continuous learning, improvement, and innovation, and encourages team members to expand their technical skill base
Qualification
Required
Expertise in cellular immunology, flowcytometry, cell-based and molecular assays with analytical testing methodologies
Understanding of the technological requirements to execute on testing and characterization needs of a cellular therapy company
Design, develop, execute, and document flow cytometry/cell/molecular based analytical methods for product characterization and investigations
Support product characterization activities, including comparability assessments in support of product life cycle management
Partner in the transfer of qualified assays within AD and to QC, and support assay validation and investigations
Develop and deliver scientific presentations, prepare clear and concise technical reports, participate in project teams as needed
Participate in the evaluation of new analytical technologies and their implementation
Provide analytical support to cross-functional project teams
Revise, review, and author assay standard operating procedures and ELNs
Contribute to building a culture that encourages continuous learning, improvement, and innovation, and encourages team members to expand their technical skill base
Preferred
Scientist II - A minimum of 11 years of experience in immunology / cell biology, plus a Bachelors or 9 years of experience plus a Masters degree
Sr. Scientist I - A minimum of 10 years of extensive experience in immunology/ cell biology, plus a Phd
Previous people management experience preferred
Well versed in wide variety of analytical techniques such as cytotoxicity assays, flowcytometry, cytokine release assays, cell counting, short term cell culture and other applicable methods
Experience in analytical development, cGMP QC testing and implementation of new technologies in a regulated environment
Experience with assessment of new technologies in a fast-paced, learning organization preferably in a cross-functional setting where impact of new technologies is evaluated across research, development, and commercial organizations
Prior experience in cell therapy development preferred
Must have excellent oral and written communication skills
Proven ability to work independently and collaboratively among cross-functional teams
Ability to work efficiently, prioritize workflow, meet deadlines and balance competing priorities
Excellent analytical skills and technical expertise
Benefits
Subsidized medical, dental and vision plans from your first day of employment
FSA
Company provided Life and AD&D Insurance
STD and LTD Insurance
ESPP
A 401(k) Plan with Company match
Mass transit commuter benefits
Cell phone reimbursement
A range of supplemental benefits that you may choose to elect
18 days’ vacation
9 day’s sick leave
8 observed holidays
A floating holiday
Summer and a winter office shutdown
Company
Lyell Immunopharma
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
201-500 employees
H1B Sponsorship
Lyell Immunopharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (2)
2022 (5)
2021 (2)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$543M2025-07-25Post Ipo Equity· $50M
2021-06-16IPO
2020-03-12Series C· $493M
Leadership Team
Lynn Seely
President & Chief Executive Officer
Gary Lee
Chief Scientific Officer
Recent News
2025-12-25
2025-12-19
2025-12-09
Company data provided by crunchbase